Bemnifosbuvir hemisulfate

Bemnifosbuvir hemisulfate
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T9331-1mg 1 mg

7 - 10 business days*

50.00€
TGM-T9331-5mg 5 mg

7 - 10 business days*

111.00€
TGM-T9331-10mg 10 mg

7 - 10 business days*

181.00€
TGM-T9331-25mg 25 mg

7 - 10 business days*

321.00€
TGM-T9331-50mg 50 mg

7 - 10 business days*

465.00€
TGM-T9331-100mg 100 mg

7 - 10 business days*

698.00€
TGM-T9331-200mg 200 mg - - -

7 - 10 business days*

940.00€
 
Description: Bemnifosbuvir hemisulfate (AT-527) is a potent inhibitor of HCV virus replication.... more
Product information "Bemnifosbuvir hemisulfate"
Description: Bemnifosbuvir hemisulfate (AT-527) is a potent inhibitor of HCV virus replication. Target: HCV Protease, SARS-CoV. Smiles: C[C@@H](C(OC(C)C)=O)N[P@@](OC1=CC=CC=C1)(OC[C@H]2O[C@@H](N3C=NC4=C(NC)N=C(N)N=C34)[C@](C)(F)[C@@H]2O)=O.C[C@@H](C(OC(C)C)=O)N[P@@](OC5=CC=CC=C5)(OC[C@H]6O[C@@H](N7C=NC8=C(NC)N=C(N)N=C78)[C@](C)(F)[C@@H]6O)=O.O=S(O)(O)=O. References: Good S S , Moussa A , Zhou X J , et al. Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus[J]. PLoS ONE, 2020, 15(1):e0227104-.
Keywords: AT-527
Supplier: TargetMol
Supplier-Nr: T9331

Properties

Application: Targets Coronaviridae replicase polyprotein 1ab (pp1ab)
MW: 1261.15 D
Formula: C48H68F2N14O18P2S

Database Information

CAS : 2241337-84-6| Matching products
KEGG ID : K22472 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Bemnifosbuvir hemisulfate"
Write a review
or to review a product.
Viewed